GISEA/OEG INTERNATIONAL SYMPOSIUM
TORINO, 10-11 MARZO 2016
“TORINO INCONTRA” CENTRO CONGRESSI - TORINO
RATIONALE
A number of European countries have set-up biologics registries to follow cohorts of patients
treated with TNF-targeted therapies and record their characteristics and clinical course over
time. As we are aware, these registries have begun to provide valuable insights into the
optimal treatment of various rheumatic conditions that can and should be used to inform
clinical decision making and to provide also important safety informations.
The educational aims of this congress are to:
•
•
•
•
•
•
Highlight the role of national biologic registers as a source of long-term, real-life data
and assess the implications for clinical practice
Review the long-term effectiveness and maintenance on therapy data from national
biologic registers
Comparing data from national biologic registers on RA and Spondyloarthritides
To stress the value of early diagnosis and treatments
Reanalyze the ultrasonography as a useful diagnostic tool in managing these diseases.
Consider the safety data emerging from national biologic registers with a particular
focus on serious infections, lymphoma and solid tumors.
GIOVEDÌ 10 MARZO 2016
12,00
Lunch
12,45 – 13,00
Apertura lavori e saluto autorità
13,00 — 13,30
Sponsored Lecture (No ECM):I Dati Real Life nei Farmaci
Biologici
Relatore: Michele Lattarulo, Bari
Moderatore: Enrico Fusaro, Torino
13,30 — 14,00
Sponsored Lecture (No ECM):Golimumab in Real Life Setting:
New emerging evidences
Relatore: Florenzo Iannone, Bari
SESSIONE I
AXIAL SPONDYLOARTHRITIS
Chairman: Roberto Caporali
14,00 — 14,15
Non radiographic axial SpA: an early phase of ankylosing
spondylitis or a different disease?
(Xenofon Baraliakos, Germany)
14,15 — 14,30
Spontaneous, drug-induced, and drug-free remission in axial
spondyloarthritis
(Ennio Favalli, Milano)
14,30 — 14,45
The role of non-pharmacologic treatment in Axial SpA
(ankylosing spondylitis)
(Elisa Gremese, Roma)
14,45 — 15,00
Discussion
SESSIONE II
EXTRA ARTICULAR COMORBIDITIES
Chairman: Fabiola Atzeni
15,00 — 15,15
Which index and questionnaires for evaluating comorbidities in
inflammatory arthritis?
(Helga Radner, Austria)
15,15 — 15,30
Ocular findings in Spondyloarthritis
(Cimino L, Reggio Emilia)
15,30 — 15,45
Cardiovascular manifestations in Spondyloarthritis
(Szekanecz Z, Hungary)
15,45 — 16,00
Discussion
16,00 — 16,15
Break
16,15 — 16,45
Sponsored Lecture (No ECM):
The choice of abatacept in early rapidly progressing patient:
lesson learned from trials and real life data
Relatore: Rosario Foti, Catania
Moderatore: Giovanni Lapadula, Bari
16,45 — 17,15
Sponsored Lecture (No ECM):
The importance of axSpA beyond sacroiliitis: solution for a
holistic approach
Relatore: Gianfranco Ferraccioli, Roma
17,15 — 17,45
Sponsored Lecture (No ECM):
Consensus tra Reumatologi e Radiologi per l’ imaging dell’ Axial
SpA
Relatori: Riccardo Faletti, Torino; Enrico Fusaro,Torino;
Raffaele Pellerito, Torino;
SESSIONE III
NEW DRUGS (IN SPA)
Chairman: Ennio Favalli
17,45 — 18,00
One step beyond TNF blockade: the IL—12/23 and IL—17
pathway in the treatment of SpA (ankylosing spondylitis)
(Luca Idolazzi, Verona)
18,00 — 18,15
New insights in the treatment of psoriatic disease: update on
phase II/III trials
(Paolo Gisondi, Verona)
18,15 — 18,30
The present and the future of preventing damage progression in
ankylosing spondylitis
(Ennio Lubrano Di Scorpaniello, Campobasso)
18,30 — 18,45
Discussion
VENERDÌ 11 MARZO 2016
09,00 — 09,30
Sponsored Lecture (No ECM):
What does MTX mean in 2016?
Relatore: Monica Todoerti, Pavia
09,30 — 10,00
Sponsored Lecture (No ECM):
The role of IL—6 inhibition in RA: tocilizumab in the treatment
algorithm
Relatore: Luigi Sinigaglia, Milano
Moderatore: Giovanni Lapadula, Bari
10,00 — 10,15
Presentazione Progetto “Medicina Comunicazionale e
Relazionale”
(Progetto rivolto all’acquisizione di competenze e conoscenze in
ambito di comunicazione medico—paziente)
Relatore: Rosario Gagliardi, Lecce
10,15 — 10,30
Break
SESSIONE I
PSORIATIC ARTHRITIS
Chairman: Florenzo Iannone
10,30 — 10,45
New insights in the pathogenesis of PsA (PSORIATIC ARTHRITIS)
(Alberto Cauli, Cagliari)
10,45 — 11,15
Lecture
Psoriatic arthritis: criteria and therapeutic algorithms
(Antonio Marchesoni, Milano)
11,15 — 11,30
Idea Project: Diagnostic algorithm and management of PsA
(PSORIATIC ARTHRITIS)
(Giovanni Lapadula, Bari)
11,30 — 12,00
Lecture
Psoriatic arthritis and real-life: data from European registries
(Tore Kvien, Oslo)
12,00 — 12,15
Psoriatic arthritis and real-life: data from GISEA registry
(Leonardo Punzi, Padova)
12,15 — 12,30
Discussion
12,30 — 14,00
Lunch
SESSIONE II
EARLY UNDIFFERENTIATED AND RHEUMATOID ARTHRITIS
Chairman: Elisa Gremese
14,00 — 14,15
Which therapeutic interventions in patients with early
undifferentiated arthritis to delay or halt disease progression?
(Bruno—Jean Fautrel, Parigi)
14,15 — 14,30
Personalized medicine: genetic and epigenetic markers
(Stefano Alivernini, Roma)
14,30 — 14,45
Corticosteroids role in Rheumatoid Arthritis management: data
from clinical trials and real life (GISEA registry)
(Roberto Caporali, Pavia)
14,45 — 15,00
Interstitial lung disease in RA (Rheumatoid Arthritis): prevalence,
prognosis and early diagnosis
(Andreina Manfredi, Modena)
15,00 — 15,15
Discussion
15,15 — 16,00
Lecture
Target terapeutici intra ed extra cellulari: pro e contro
(Fabrizio Conti, Roma — Gianfranco Ferraccioli, Roma)
SESSIONE III
REACTIVE ARTHRITIS AND ENTEROPATHIC ARTHRITIS
Chairman: Marco Sebastiani
16,00 — 16,15
Reactive arthritis: from anti-infiammatory drugs to DMARDs and
biologics
(Fabiola Atzeni, Milano)
16,15 — 16,30
Epidemiology and clinical course of IBD—associated SpA
(ankylosing spondylitis)
(Carlo Salvarani, Reggio Emilia)
16,30 — 16,45
Need for integrated approach for IBD—associated SpA
(ankylosing spondylitis) patient management
(Paolo Gionchetti, Bologna)
Discussion
16,45 — 17,00
SESSIONE IV
IMAGING INTEGRATO NEL COINVOLGIMENTO ASSIALE DELLE
SPONDILOARTRITI
Chairman: Fausto Salaffi
17,00 — 17,15
Lesioni elementari in radiologia convenzionale
(Fausto Salaffi, Jesi)
17,15 — 17,30
Ruolo della risonanza magnetica e della tomografia
computerizzata
(Marina Carotti, Jesi)
17,30 — 17,45
Discussion
17,45 - Fine:
ECM TEST